Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 7, 2018. The report announces a significant executive leadership change, specifically the appointment of Iain Mackay as the next Chief Financial Officer (CFO) and Executive Director.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and governance.
Executive Compensation Details
- Base Salary: £850,000
- Annual Bonus: £850,000 (on-target), with a maximum of 200%.
- Long-Term Incentives (LTIs): £1,700,000 (expected value based on 4x base salary multiple).
- Share Ownership Requirement: 300% of base salary.
Material Changes
The primary material change is the succession planning for the CFO role:
- Outgoing CFO: Simon Dingemans is scheduled to retire in May 2019.
- Incoming CFO: Iain Mackay joins from HSBC, where he served as Group Finance Director for 8 years.
- Transition Timeline:
- January 14, 2019: Mr. Mackay joins the Corporate Executive Team and Board as CFO Designate.
- April 1, 2019: Mr. Mackay assumes formal accountability as CFO.
- March 2019: Mr. Dingemans remains accountable for financial governance until this date.
Outlook, Risks, and Management Commentary
Management Commentary: CEO Emma Walmsley highlighted Mr. Mackay's experience in complex, regulated global organizations and his track record in driving cost, cash, and capital allocation discipline. Chairman Philip Hampton noted the value of his cross-sector experience.
Risks and Contingencies: The filing includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the 2017 Annual Report on Form 20-F. No specific new operational risks or contingencies were disclosed in this text.
Investor Verification Checklist
- Verify the exact start date of Iain Mackay's formal CFO accountability (April 1, 2019) versus his Board appointment date (January 14, 2019).
- Confirm the retirement timeline for outgoing CFO Simon Dingemans (May 2019).
- Review the full employment contract for Iain Mackay, available for inspection at the registered office and website by January 14, 2019.
- Check the 2017 Annual Report on Form 20-F for detailed risk factors referenced in the cautionary statement.